|
Advancing Climate Action, Governance Excellence, and Global Scientific Impact
PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of responsible innovation in biotechnology and reinforcing its role as a trusted global partner powering the future of healthcare, science, and sustainability.
At a time when biotech is increasingly central to global health, and climate resilience, GenScript's ESG Report demonstrates how the company is embedding sustainability, governance, and societal impact into its growth strategy - not as an obligation, but as a competitive advantage.
"Sustainability is not adjacent to our strategy; it is embedded within it," said Sherry Shao, Rotating CEO of GenScript. "In 2025, we strengthened governance, accelerated climate action, advanced responsible supply chains, and continued building a diverse, high-performing global organization. As biotechnology reshapes the future, we are committed to doing so responsibly - creating long-term value for society, our partners, and our stakeholders."
FROM FRAMEWORK TO FORCE: ESG AS A STRATEGIC GROWTH ENGINE
GenScript's 2025 ESG Report moves beyond reporting, to demonstrate a system-level execution - structured around five core pillars - governance, workforce, environment, supply chain, and community - operating as integrated drivers of long-term value creation.
The company's ESG strategy is aligned with its mission 'to make people and nature healthier through biotechnology' and reflects a data-driven, globally consistent, and operationally embedded approach to sustainability.
2025 ESG HIGHLIGHTS
1) Governance That Scales with Global Impact
- Board-level oversight through the Risk Management and ESG Committee ensures enterprise-wide accountability and resilience
- 100% coverage of employee ethics training and conflict-of-interest evaluations reinforces integrity at scale
- Globally unified governance aligned with leading regulatory and compliance standards
2) Responsible Supply Chain Management Enabling Customers Worldwide
- Active Supplier Partner of the Pharmaceutical Supply Chain Initiative
- 100% of targeted suppliers aligned with GenScript's Supplier Code of Conduct
- ESG audits, risk mitigation, and Supplier Day engagement driving resilient, transparent supply ecosystems
3) A High-Performance, Inclusive Global Workforce
- 6,165 employees worldwide, with 58% female representation and nearly 50% women in leadership roles
- Continued investment in career development, training, and competitive benefits to attract and retain top biotech talent
- Recognized as a Global Talent Magnet Employer by LinkedIn
4) Preserving Environment Backed by Science
- Decarbonization targets officially validated by the Science Based Targets initiative, aligning with a 1.5°C pathway and net-zero ambition by 2050
- Uninterrupted energy efficiency, renewable energy adoption, & process optimization
- Systematic climate risk assessment embedded into enterprise risk management
5) Community Impact Through Perpetual Action
- Over 1,400 global volunteer hours contributed across environmental protection, healthcare, education, and community initiatives
- Continued collaboration with global partners to accelerate therapeutic innovation and expand patient access
GLOBAL RECOGNITION REINFORCING CREDIBILITY AND MOMENTUM
GenScript's ESG performance continues to earn top-tier international recognition, validating its disciplined, measurable, and transparent approach:
- MSCI ESG Rating: AA
- EcoVadis: Silver Medal
- Sustainalytics: Low Risk
- Inclusion in the S&P Global Sustainability Yearbook 2026
- Member of the FTSE4Good Index Series
These recognitions position GenScript among the leading responsible players in the global life sciences and biotech services sector.
SUPPORTING SUSTAINABLE GROWTH IN BIOTECHNOLOGY
The 2025 ESG Report underscores GenScript's continued focus on aligning business growth with responsible practices, as the company expands its global presence and contributes to the evolution of a more resilient and accountable biotechnology sector.
This combination of innovation + governance + trust is what differentiates GenScript; not just as a service provider, but as a strategic enabler of the future of biotechnology.
Access the Full Report: The full 2025 ESG Report is available at:
EN: https://www.genscript.com/gsfiles/esg/2025-ESG-Report.pdf
About GenScript Biotech Corporation
Founded in 2002 in New Jersey, GenScript Biotech Corporation (HKEX: 1548) accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products. As a cornerstone of the global life science ecosystem, GenScript actively collaborates with a diverse network of partners - from academic institutions to industry leaders - to co-create cutting-edge solutions that redefine service excellence.
Guided by its mission to Make People and Nature Healthier Through Biotechnology, GenScript has become a trusted global partner with a team of 6,100+ employees, supporting over 200,000 customers across 100+ countries and regions, including the world's Top 20 pharma companies.
For More Information, Media Contacts:
Melis Inceer
Head of Integrated Communications & Content
Melis.Inceer@genscript.com
Kate Grusich
Senior Corporate Communications Manager
Katherina.Grusich@genscript.com
Advancing Climate Action, Governance Excellence, and Global Scientific Impact
PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of responsible innovation in biotechnology and reinforcing its role as a trusted global partner powering the future of healthcare, science, and sustainability.
At a time when biotech is increasingly central to global health, and climate resilience, GenScript's ESG Report demonstrates how the company is embedding sustainability, governance, and societal impact into its growth strategy - not as an obligation, but as a competitive advantage.
"Sustainability is not adjacent to our strategy; it is embedded within it," said Sherry Shao, Rotating CEO of GenScript. "In 2025, we strengthened governance, accelerated climate action, advanced responsible supply chains, and continued building a diverse, high-performing global organization. As biotechnology reshapes the future, we are committed to doing so responsibly - creating long-term value for society, our partners, and our stakeholders."
FROM FRAMEWORK TO FORCE: ESG AS A STRATEGIC GROWTH ENGINE
GenScript's 2025 ESG Report moves beyond reporting, to demonstrate a system-level execution - structured around five core pillars - governance, workforce, environment, supply chain, and community - operating as integrated drivers of long-term value creation.
The company's ESG strategy is aligned with its mission 'to make people and nature healthier through biotechnology' and reflects a data-driven, globally consistent, and operationally embedded approach to sustainability.
2025 ESG HIGHLIGHTS
1) Governance That Scales with Global Impact
- Board-level oversight through the Risk Management and ESG Committee ensures enterprise-wide accountability and resilience
- 100% coverage of employee ethics training and conflict-of-interest evaluations reinforces integrity at scale
- Globally unified governance aligned with leading regulatory and compliance standards
2) Responsible Supply Chain Management Enabling Customers Worldwide
- Active Supplier Partner of the Pharmaceutical Supply Chain Initiative
- 100% of targeted suppliers aligned with GenScript's Supplier Code of Conduct
- ESG audits, risk mitigation, and Supplier Day engagement driving resilient, transparent supply ecosystems
3) A High-Performance, Inclusive Global Workforce
- 6,165 employees worldwide, with 58% female representation and nearly 50% women in leadership roles
- Continued investment in career development, training, and competitive benefits to attract and retain top biotech talent
- Recognized as a Global Talent Magnet Employer by LinkedIn
4) Preserving Environment Backed by Science
- Decarbonization targets officially validated by the Science Based Targets initiative, aligning with a 1.5°C pathway and net-zero ambition by 2050
- Uninterrupted energy efficiency, renewable energy adoption, & process optimization
- Systematic climate risk assessment embedded into enterprise risk management
5) Community Impact Through Perpetual Action
- Over 1,400 global volunteer hours contributed across environmental protection, healthcare, education, and community initiatives
- Continued collaboration with global partners to accelerate therapeutic innovation and expand patient access
GLOBAL RECOGNITION REINFORCING CREDIBILITY AND MOMENTUM
GenScript's ESG performance continues to earn top-tier international recognition, validating its disciplined, measurable, and transparent approach:
- MSCI ESG Rating: AA
- EcoVadis: Silver Medal
- Sustainalytics: Low Risk
- Inclusion in the S&P Global Sustainability Yearbook 2026
- Member of the FTSE4Good Index Series
These recognitions position GenScript among the leading responsible players in the global life sciences and biotech services sector.
SUPPORTING SUSTAINABLE GROWTH IN BIOTECHNOLOGY
The 2025 ESG Report underscores GenScript's continued focus on aligning business growth with responsible practices, as the company expands its global presence and contributes to the evolution of a more resilient and accountable biotechnology sector.
This combination of innovation + governance + trust is what differentiates GenScript; not just as a service provider, but as a strategic enabler of the future of biotechnology.
Access the Full Report: The full 2025 ESG Report is available at:
EN: https://www.genscript.com/gsfiles/esg/2025-ESG-Report.pdf
About GenScript Biotech Corporation
Founded in 2002 in New Jersey, GenScript Biotech Corporation (HKEX: 1548) accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products. As a cornerstone of the global life science ecosystem, GenScript actively collaborates with a diverse network of partners - from academic institutions to industry leaders - to co-create cutting-edge solutions that redefine service excellence.
Guided by its mission to Make People and Nature Healthier Through Biotechnology, GenScript has become a trusted global partner with a team of 6,100+ employees, supporting over 200,000 customers across 100+ countries and regions, including the world's Top 20 pharma companies.
For More Information, Media Contacts:
Melis Inceer
Head of Integrated Communications & Content
Melis.Inceer@genscript.com
Kate Grusich
Senior Corporate Communications Manager
Katherina.Grusich@genscript.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
SINGAPORE, June 3, 2026 /PRNewswire/ -- Star Living has unveiled a new all-in-one home planning concept aimed at helping Singapore homeowners manage renovation, furnishing, and home appliance selection through a more coordinated and efficient process.
As renovation projects become increasingly complex, many homeowners are looking for ways to reduce the challenges of managing multiple contractors, suppliers, and retailers separately. Star Living's latest initiative brings together renovation-related services, furnishings, electrical appliances, and sanitary solutions under a single customer experience designed to simplify project coordination.
Addressing Growing Demand for More Coordinated Home Planning
Today's homeowners are placing greater emphasis on practicality, time efficiency, and cohesive planning when designing their homes.
To support these evolving expectations, Star Living now offers a broader range of services including:
- Carpentry and customised built-ins
- Masonry and flooring works
- Air-conditioning installation
- Bathroom fittings and sanitary installation
- Interior consultation
- Furniture and mattress collections
- Home appliances and household essentials
Through this consolidated approach, customers can manage multiple aspects of their renovation and furnishing requirements through a single touchpoint, helping to reduce administrative complexity and improve planning efficiency.
"We want to make the renovation and furnishing process more manageable for homeowners. By bringing these services together, customers can enjoy a more seamless experience when planning their homes," said Koh Hong Jie, Group Retail Manager at Star Living.
Expanding Interior Solutions with OPU Door
As part of its broader product expansion, Star Living has also introduced OPU Door, a distributed door system brand offering contemporary door solutions designed for space-conscious residential interiors.
Launched in 2025, the collection includes:
- Slim-frame aluminium core doors
- Concealed doors for minimalist interiors
- Synchronised sliding door systems
- Phantom doors designed for tighter layouts and space optimisation
The range caters to homeowners seeking cleaner visual aesthetics while maximising functionality within compact urban homes.
Adapting to Lifestyle and Material Preferences
The company has also expanded its offerings in response to changing consumer preferences surrounding sustainability, wellness-focused materials, and pet-friendly home environments.
Its current product selections include:
- Low-formaldehyde materials
- Sustainably sourced furniture
- Scratch-resistant and stain-resistant upholstery fabrics suitable for pet owners
As part of its material standards, Star Living uses E1-grade or higher MDF and CARB P2-certified boards. The company has also been awarded the SFIC Sustainability Furniture Mark in recognition of its environmental and health-conscious practices.
Creating a More Connected Retail Experience
Star Living's showroom at Serangoon North reflects the company's lifestyle-oriented retail approach by presenting furnishings, renovation elements, sanitary fittings, and appliances within coordinated home settings.
The showroom is designed to help customers better visualise how different components can come together within a residential environment before making purchasing decisions.
In addition, Star Living works with established air-conditioning brands including Daikin, Midea, Panasonic, and Mitsubishi Electric to support a broader range of household needs.
Positioned for Evolving Consumer Needs
Established in 1981, Star Living continues to evolve alongside shifting homeowner expectations by focusing on practical home planning, coordinated services, and adaptable interior solutions.
By combining renovation-related services with furnishings, sanitary solutions, and appliances, the company aims to provide a more efficient and accessible approach for customers planning their homes.
About Star Living
Star Living is a Singapore-based home and lifestyle brand operated by Star Furniture Pte Ltd. Established in 1981, the brand offers a comprehensive range of furniture, home furnishings, renovation-related services, sanitary solutions, and household products, serving residential customers across Singapore.
Website: https://www.starliving.com.sg/
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Star Living Introduces Integrated 'One-Stop Home & Living' Concept to Simplify Renovation and Furnishing for Singapore Homeowners
